v3.26.3
OPTIONS
9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
OPTIONS

NOTE 12 – OPTIONS

 

The Plan allows for and the Company maintains stock option award agreements under which certain employees may be awarded option grants based on a combination of performance and tenure. The number of shares available to grant to employees under the Plan is 200,000.

 

The Board and stockholders approved an amendment to the Plan increasing the available shares under the Plan to 200,000 shares of the Common Stock as such common stock existed on July 24, 2024.

 

Total compensation cost related to stock options granted was $0 for both the three and nine months ended September 30, 2026, and $144,565 and $307,440 for the three and nine months ended September 30, 2025, respectively.

 

On September 17, 2025, the Company cancelled 80,000 stock options and granted the related option holders 80,000 shares of common stock. This modification resulted in the Company recognizing the remaining expense under the original option and an additional incremental consideration as a result of the modification. Total stock-based compensation cost as a result of this transaction was $1,512,994.

 

The following table represents stock option activity for the nine-month period ended September 30, 2026:

 

   Number Outstanding  

Weighted- Average

Exercise Price

  

Weighted-

Average

Contractual Life in Years

   Intrinsic Value 
Options outstanding as of December 31, 2025   795   $739.54    2.23   $- 
Options granted   -    -    -    - 
Options cancelled   -    -    -    - 
Forfeited/expired   (74)   1,710.41    -    - 
Options exercised   -    -    -    - 
Options outstanding as of September 30, 2026   721   $624.26    1.67   $- 
Options exercisable as of September 30, 2026   721   $624.26    1.67    -